Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330473 · ClinicalTrials.gov registry record · Phase 3
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,019
- Enrollment target
NCT00330473 is a Phase 3 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 1,019 participants.
The verdict
NCT00330473, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,019 participants
- Enrollment target
Study Summary
A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.
Interventions
- DRUG Insulin
- DRUG Human Insulin Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,019 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330473
The ClinicalTrials.gov registry entry for NCT00330473 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,019 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00330473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330473 about?
NCT00330473 is a clinical study titled "A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes". A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.
What is the current status of trial NCT00330473?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,019 participants. The study started on 2006-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00330473?
The interventions under investigation include: Insulin (DRUG), Human Insulin Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00330473?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.